120 DIETARY INTERVENTION INHIBITS COLONIC INFLAMMATION BY TARGETING PATHOBIONTS IN A NEW MODEL OF CROHN'S DISEASE

2020 ◽  
Vol 158 (6) ◽  
pp. S-21-S-22
Author(s):  
Roberta Caruso ◽  
Peter Kuffa ◽  
Naohiro Inohara ◽  
Gabriel Nunez
2021 ◽  
Vol 160 (3) ◽  
pp. S53-S54
Author(s):  
Roberta Caruso ◽  
Peter Kuffa ◽  
Naohiro Inohara ◽  
Gabriel Nunez

2019 ◽  
Vol 25 (Supplement_1) ◽  
pp. S10-S10
Author(s):  
Kelli E DuBois ◽  
Michael Beets ◽  
Christine Blake ◽  
Jennifer McCabe

2020 ◽  
Vol 158 (6) ◽  
pp. S-689
Author(s):  
Mariangela Allocca ◽  
Gionata Fiorino ◽  
Federica Furfaro ◽  
Alessandra Zilli ◽  
Daniela Gilardi ◽  
...  

2003 ◽  
Vol 124 (4) ◽  
pp. A518 ◽  
Author(s):  
Eran Israeli ◽  
Eran Goldin ◽  
Nilla Hemed ◽  
Barbara Thalenfeld ◽  
Dean Engelhardt ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 655
Author(s):  
Ugo Cucinotta ◽  
Claudio Romano ◽  
Valeria Dipasquale

Both genetic and environmental factors are involved in the onset of inflammatory bowel disease (IBD). In particular, diet composition is suspected to significantly contribute to IBD risk. In recent years, major interest has raised about the role of nutrition in disease pathogenesis and course, and many studies have shown a clear link between diet composition and intestinal permeability impairment. Moreover, many IBD-related factors, such as poor dietary intake, nutrients loss and drugs interact with nutritional status, thus paving the way for the development of many therapeutic strategies in which nutrition represents the cornerstone, either as first-line therapy or as reversing nutritional deficiencies and malnutrition in IBD patients. Exclusive enteral nutrition (EEN) is the most rigorously supported dietary intervention for the treatment of Crohn’s Disease (CD), but is burdened by a low tolerability, especially in pediatric patients. Promising alternative regimens are represented by Crohn’s Disease Exclusion Diet (CDED), and other elimination diets, whose use is gradually spreading. The aim of the current paper is to provide a comprehensive and updated overview on the latest evidence about the role of nutrition and diet in pediatric IBD, focusing on the different nutritional interventions available for the management of the disease.


PLoS ONE ◽  
2021 ◽  
Vol 16 (5) ◽  
pp. e0252334
Author(s):  
Ji Zhang ◽  
Xue-jun Wang ◽  
Li-jie Wu ◽  
Ling Yang ◽  
Yan-ting Yang ◽  
...  

Crohn’s disease is a chronic inflammatory bowel disease and the NLRP3 inflammasome plays an important role in Crohn’s disease. Previous studies have shown that Herb-partitioned moxibustion treating (at Qihai (CV 6) and Tianshu (ST 25)) prevented the excessive activation of the NLRP3 inflammasome and repaired damaged colonic mucosa in Crohn’s disease. However, the mechanism by which Herb-partitioned moxibustion (at CV 6 and ST 25) regulates NLRP3 remains unclear. In this study, we treated Crohn’s disease rats with herb-partitioned moxibustion (at CV 6 and ST 25) to investigate the mechanism by which Herb-partitioned moxibustion regulates the colonic NLRP3 inflammasome by observing colon length, the colon macroscopic damage indexes, and the expression of ATP, P2X7R, Pannexin-1, NF-κBp65, NLRP3, ASC, caspase-1, IL-1β and IL-18 in the colon in Crohn’s disease. Here, this study shows that herb-partitioned moxibustion (at CV 6 and ST 25) can reduce colon macroscopic damage indexes and colon histopathological scores, alleviate colon shortening and block the abnormal activation of the NLRP3 inflammasome by inhibiting the ATP content and the expression of P2X7R, Pannexin-1 and NF-κBp65, thereby reducing the release of the downstream inflammatory cytokine IL-1β and ultimately suppressing colonic inflammation in Crohn’s disease rats. This study for the first time identifies the mechanism by which herb-partitioned moxibustion (at CV 6 and ST 25) may inhibit the abnormal activation of the NLRP3 inflammasome by inhibiting the P2X7R-Pannexin-1 signaling pathway in Crohn’s disease rats.


2009 ◽  
Vol 136 (5) ◽  
pp. A-560
Author(s):  
Simone C. Wolfkamp ◽  
Pieter Stokkers ◽  
Esther W. Vogels ◽  
Noor L. Bekkali ◽  
Fiebo J. Ten Kate ◽  
...  

2020 ◽  
Vol 14 (11) ◽  
pp. 1547-1557 ◽  
Author(s):  
Zhengxiao Zhang ◽  
Lorian Taylor ◽  
Nusrat Shommu ◽  
Subrata Ghosh ◽  
Raylene Reimer ◽  
...  

Abstract Background and Aims Crohn’s disease [CD] is associated with alterations in gut microbial composition and function. The present controlled-intervention study investigated the relationship between patterns of dietary intake and baseline gut microbiota in CD patients in remission and examined the effects of a dietary intervention in patients consuming a non-diversified diet [NDD]. Methods Forty outpatients with quiescent CD were recruited in Calgary, Alberta, Canada. Based on 3-day food records, patients consuming a lower plant-based and higher red and processed meat-based diet were assigned to the NDD group [n = 15] and received a 12-week structured dietary intervention; all other patients were assigned to the diversified diet [DD] control group [n = 25] and received conventional management. Faecal microbiota composition, short chain fatty acids [SCFAs] and calprotectin were measured. Results At baseline the NDD and DD groups had a different faecal microbial beta-diversity [p = 0.003, permutational multivariate analysis of variance]. The NDD group had lower Faecalibacterium and higher Escherichia/Shigella relative abundances compared to the DD group [3.3 ± 5.4% vs. 8.5 ± 10.6%; 6.9 ± 12.2% vs. 1.6 ± 4.4%; p ≤ 0.03, analysis of covariance]. These two genera showed a strong negative correlation [rs = −0.60, q = 0.0002]. Faecal butyrate showed a positive correlation with Faecalibacterium [rs = 0.52, q = 0.002], and an inhibitory relationship with Escherichia/Shigella abundance [four-parameter sigmoidal model, R = −0.83; rs = −0.44, q = 0.01], respectively. After the 12 weeks of dietary intervention, no difference in microbial beta-diversity between the two groups was observed [p = 0.43]. The NDD group demonstrated an increase in Faecalibacterium [p < 0.05, generalized estimated equation model], and resembled the DD group at the end of the intervention [p = 0.84, t-test with permutation]. We did not find an association of diet with faecal SCFAs or calprotectin. Conclusions Dietary patterns are associated with specific gut microbial compositions in CD patients in remission. A diet intervention in patients consuming a NDD modifies gut microbial composition to resemble that seen in patients consuming a DD. These results show that diet is important in shaping the microbial dysbiosis signature in CD towards a balanced community.


Sign in / Sign up

Export Citation Format

Share Document